Scarica l'app Stockscreener
0.43
5.99%
-0.0274
Dopo l'orario di chiusura:
.38
-0.05
-11.63%
Precedente Chiudi:
$0.4574
Aprire:
$0.4568
Volume 24 ore:
2.12M
Relative Volume:
0.29
Capitalizzazione di mercato:
$22.28M
Reddito:
-
Utile/perdita netta:
$-563.30K
Rapporto P/E:
-2.1543
EPS:
-0.1996
Flusso di cassa netto:
$-22.23M
1 W Prestazione:
-18.17%
1M Prestazione:
-38.67%
6M Prestazione:
-44.80%
1 anno Prestazione:
-67.42%
Intervallo 1D:
$0.415
$0.4568
Intervallo di 1 settimana:
$0.415
$0.5488
Portata 52W:
$0.38
$1.59
Promis Neurosciences Inc Stock (PMN) Company Profile
Nome
Promis Neurosciences Inc
Settore
Industria
Telefono
416-847-6898
Indirizzo
SUITE 200, 1920 YONGE STREET, TORONTO
Confronta PMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PMN
Promis Neurosciences Inc
|
0.43 | 27.80M | 0 | -563.30K | -22.23M | -0.1996 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Promis Neurosciences Inc Borsa (PMN) Ultime notizie
Sector ETF performance correlation with ProMIS Neurosciences Inc.2025 Technical Overview & Real-Time Buy Signal Alerts - Newser
Applying Wyckoff theory to ProMIS Neurosciences Inc. stockQuarterly Investment Review & Daily Stock Trend Reports - Newser
Technical analysis overview for ProMIS Neurosciences Inc. stockCEO Change & Consistent Profit Trade Alerts - Newser
ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310 - Ariva
Live market analysis of ProMIS Neurosciences Inc.July 2025 Closing Moves & Weekly Top Gainers Alerts - Newser
ProMIS Neurosciences' PMN310: A Safer, Differentiated Alzheimer’s Therapy with Strong Clinical and Regulatory Momentum - AInvest
ProMIS Neurosciences Gets Approval to Advance Alzheimer's Disease Treatment to Final Dose Escalation - MarketScreener
ProMIS Neurosciences Receives DSMB Approval to Advance to - GlobeNewswire
ProMIS Neurosciences Receives DSMB Approval for PMN310 Alzheimer's Trial to Advance to Final Dose Cohort. - AInvest
Zero ARIA Cases: ProMIS's Novel Alzheimer's Drug PMN310 Advances to Final Trial Phase with Clean Safety Data - Stock Titan
Ranking ProMIS Neurosciences Inc. among high performing stocks via toolsWeekly Risk Summary & Weekly Momentum Picks - Newser
Has ProMIS Neurosciences Inc. formed a bullish divergenceQuarterly Portfolio Report & Verified Momentum Watchlists - Newser
Why ProMIS Neurosciences Inc. is moving todayJuly 2025 Fed Impact & Scalable Portfolio Growth Methods - Newser
What indicators show strength in ProMIS Neurosciences Inc.Weekly Stock Report & Short-Term High Return Ideas - Newser
Relative strength of ProMIS Neurosciences Inc. in sector analysisWeekly Market Report & AI Forecasted Entry/Exit Points - Newser
ProMIS Neurosciences Inc. stock trend forecastWeekly Trading Summary & Weekly Return Optimization Plans - Newser
Will ProMIS Neurosciences Inc. see short term momentumJuly 2025 Fed Impact & AI Powered Market Entry Strategies - Newser
ProMIS Neurosciences Inc. stock outlook for YEARJuly 2025 Update & Real-Time Chart Pattern Alerts - Newser
Using economic indicators to assess ProMIS Neurosciences Inc. potentialBear Alert & Low Drawdown Momentum Trade Ideas - Newser
Is ProMIS Neurosciences Inc. stock entering bullish territoryTrade Risk Assessment & AI Based Trade Execution Alerts - Newser
Visualizing ProMIS Neurosciences Inc. stock with heatmaps2025 Technical Overview & Smart Investment Allocation Tips - Newser
Volatility clustering patterns for ProMIS Neurosciences Inc.2025 Market Sentiment & Daily Market Momentum Tracking - Newser
Published on: 2025-09-02 09:26:18 - Newser
Is ProMIS Neurosciences Inc. stock influenced by commodity pricesGold Moves & Daily Volume Surge Trade Alerts - khodrobank.com
Published on: 2025-09-02 04:17:09 - Newser
What’s the recovery path for long term holders of ProMIS Neurosciences Inc.July 2025 Volume & Daily Growth Stock Tips - Newser
Is ProMIS Neurosciences Inc. backed by strong institutional buyingPortfolio Risk Report & Fast Gain Stock Tips - khodrobank.com
Is ProMIS Neurosciences Inc.’s ROIC above industry averageNew Guidance & Stock Portfolio Risk Control - khodrobank.com
How to track smart money flows in ProMIS Neurosciences Inc.2025 Trading Volume Trends & Real-Time Volume Spike Alerts - Newser
What MACD signals say about ProMIS Neurosciences Inc.Quarterly Portfolio Report & Long-Term Capital Growth Strategies - Newser
Stock Analysis: Is ProMIS Neurosciences Inc. backed by strong institutional buying2025 Historical Comparison & Fast Moving Trade Plans - khodrobank.com
Should I buy ProMIS Neurosciences Inc. stock nowEarnings Growth Summary & Growth Focused Stock Reports - khodrobank.com
Using data tools to time your ProMIS Neurosciences Inc. exitMarket Activity Summary & Breakout Confirmation Alerts - Newser
Top chart patterns to watch in ProMIS Neurosciences Inc.Quarterly Profit Report & Weekly Watchlist for Consistent Profits - Newser
What momentum shifts mean for ProMIS Neurosciences Inc.Market Trend Report & Intraday High Probability Setup Alerts - Newser
Analyzing drawdowns of ProMIS Neurosciences Inc. with statistical toolsEntry Point & Real-Time Market Trend Scan - Newser
Is ProMIS Neurosciences Inc. stock poised for growthMarket Trend Summary & Entry Point Confirmation Alerts - Newser
Exit strategy if you’re trapped in ProMIS Neurosciences Inc.July 2025 Selloffs & Free High Return Stock Watch Alerts - Newser
Is ProMIS Neurosciences Inc. stock ready for a breakout2025 Technical Patterns & Risk Controlled Swing Alerts - Newser
What is the implied volatility of ProMIS Neurosciences Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Promis Neurosciences Inc Azioni (PMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Promis Neurosciences Inc Azioni (PMN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Shafmaster Madge K. | Director |
Sep 24 '24 |
Buy |
1.30 |
70,000 |
91,028 |
208,333 |
| Shafmaster Madge K. | Director |
Sep 23 '24 |
Buy |
1.28 |
70,000 |
89,656 |
138,333 |
| Shafmaster Madge K. | Director |
Sep 20 '24 |
Buy |
1.25 |
60,000 |
75,066 |
68,333 |
| GORDON MICHAEL S | 10% Owner |
Sep 16 '24 |
Buy |
1.22 |
76,931 |
94,071 |
76,931 |
| GORDON MICHAEL S | 10% Owner |
Sep 17 '24 |
Buy |
1.40 |
16,292 |
22,809 |
93,223 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):